FDA Inspection 1002815 — Qiagen GmbH
The FDA completed an inspection of Qiagen GmbH on February 9, 2017 in Hilden. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 9, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Hilden (Germany)
Additional Details
Postmarket Audit Inspections